Pay in 4 interest-free payments of $6.05 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
And how does the process work
Cost-effectiveness studies conducted in the UK, Portugal, Canada, and the United States consistently concluded that semaglutide is cost-effective relative to lifestyle management and other pharmacotherapies, including liraglutide ( The present analysis builds on this literature by providing country-specific evidence for Greece, where liraglutide remains the only reimbursed obesity pharmacotherapy and is restricted to adults with morbid obesity and established cardiovascular disease or sleep apnoea
Eur Heart J 31:773776 Noyan-Ashraf MH, Momen MA, Ban K, Sadi AM, Zhou YQ, Riazi AM et al (2009) GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice
A systematic review ScienceDirect science/article/pii/S2214623724000048 [62] Value of GLP-1 receptor agonists versus long-acting insulins for type 2 diabetes patients with and without established cardiovascular or chronic kidney diseases: A model-based cost-effectiveness analysis using real-world data ScienceDirect science/article/abs/pii/S0168822723001006 [63] GLP-1 receptor agonists: A novel pharmacotherapy for binge eating (Binge eating disorder and bulimia nervosa)
Summer storage tips During hot months, pay extra attention to delivery timing
US$ 29.59
US$ 25.10
US$ 24.24
